TokenPost·
MBX Biosciences Posts $1.29 GAAP Loss Per Share in Q3
The company expects its $481.6 million in cash and investments to support operations into 2029.
More news
- TokenPostBitcoin-Focused Fear Gauge Records a Reading of 32 on Nov. 9
- Crypto BriefingCoreWeave plans multibillion-dollar chip-backed debt deal for expansion
- TokenPostAlgorand Says USDC Set a New Annual Transaction Record on Its Network
- TokenPostRani Therapeutics Posts $1.7 Million in Q3 Revenue, $0.04 GAAP Loss Per Share
- TokenPostEthereum Genesis Address Sends 0.05 Ether (ETH) After 11.3 Years
- TokenPostCannae Reports $312 Million in Q3 Revenue, Up 191.9% Year Over Year